The benefits of abciximab questioned in percutaneous coronary interventions following pretreatment with high-dose clopidogrel. Review uri icon

Overview

publication date

  • March 1, 2005

Research

keywords

  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal
  • Coronary Artery Disease
  • Immunoglobulin Fab Fragments
  • Ticlopidine

Identity

Scopus Document Identifier

  • 17144368818

Digital Object Identifier (DOI)

  • 10.1517/13543784.14.3.335

PubMed ID

  • 15833064

Additional Document Info

volume

  • 14

issue

  • 3